Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and has become a serious public health problem worldwide. Dipeptidyl peptidase-4 (DPP4) inhibitors, an emerging drug for the treatment of diabetes, have been found to have renoprotective effects in addition to glucose-lowe...
Saved in:
Main Authors: | Xinyu Wang (Author), Jiaqing Xiang (Author), Guixiao Huang (Author), Lin Kang (Author), Guangyan Yang (Author), Han Wu (Author), Kewei Jiang (Author), Zhen Liang (Author), Shu Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis
by: Qi Ge, et al.
Published: (2020) -
Preliminary assessment of two non-destructive instrumental techniques for quality evaluation of Lobelia chinensis Lour.
by: Hong-Peng Chen, et al.
Published: (2016) -
Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
by: Chuanrui Ma, et al.
Published: (2021) -
MicroRNA‐92b in the skeletal muscle regulates exercise capacity via modulation of glucose metabolism
by: Shu Yang, et al.
Published: (2023) -
KLF13 restrains Dll4‐muscular Notch2 axis to improve the muscle atrophy
by: Shu Yang, et al.
Published: (2024)